Sumit Maji, Bipla Debnath, Shambo Panda, Tanushree Manna, Arindam Maity, Richa Dayaramani, Rajarshi Nath, Shah Alam Khan, Md Jawaid Akhtar
Sulfur-containing heterocyclic derivatives have been disclosed for binding with a wide range of cancer-specific protein targets. Various interesting derivatives of sulfur-containing heterocyclics such as benzothiazole, thiazole, thiophene, thiazolidinedione, benzothiophene, and phenothiazine, etc have been shown to inhibit diverse signaling pathways implicated in cancer. Significant progress has also been made in molecular targeted therapy against specific enzymes such as kinase receptors due to potential binding interactions inside the ATP pocket...
May 9, 2024: Chemistry & Biodiversity